ATAC - Endometrial Sub-Protocol
NCT00814125 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 285
Last updated 2009-05-01
Summary
To compare the difference between the ARIMIDEX group and the tamoxifen group in the incidence of abnormal endometrial histological findings arising after treatment has commenced.
Conditions
Interventions
- DRUG
-
Anastrozole (Arimidex)
1mg, orally, once daily
- DRUG
-
Tamoxifen (Nolvadex)
20mg, orally, once daily
- DRUG
-
Nolvadex placebo
- DRUG
-
Arimidex placebo
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-06-30
- Completion
- 2005-12-31
More Related Trials
-
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
NCT01151215 ·Status: TERMINATED ·Phase: PHASE2
-
ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years
NCT00286117 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients
NCT00309491 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer
NCT00038467 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer
NCT00241449 ·Status: COMPLETED ·Phase: PHASE3
-
Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer
NCT00562458 ·Status: COMPLETED
-
A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
NCT00274469 ·Status: COMPLETED ·Phase: PHASE2
-
PROACT - Pre-Operative Arimidex Compared To Tamoxifen
NCT00232661 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer
NCT00259090 ·Status: COMPLETED ·Phase: PHASE2
-
Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer
NCT00002581 ·Status: COMPLETED ·Phase: PHASE3
-
ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.
NCT00291759 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
NCT00003418 ·Status: UNKNOWN ·Phase: PHASE3
-
Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer
NCT03874325 ·Status: TERMINATED ·Phase: PHASE2
-
The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
NCT00065325 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery
NCT00541086 ·Status: UNKNOWN ·Phase: PHASE3
-
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer
NCT00032136 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
NCT00044291 ·Status: COMPLETED ·Phase: PHASE3
-
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
NCT00002582 ·Status: COMPLETED ·Phase: PHASE3
-
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
NCT00186121 ·Status: COMPLETED ·Phase: PHASE2
-
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
NCT00002864 ·Status: COMPLETED ·Phase: PHASE3
-
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
NCT00002460 ·Status: UNKNOWN ·Phase: PHASE3
-
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
NCT00002967 ·Status: COMPLETED ·Phase: PHASE3
-
AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.
NCT00454805 ·Status: COMPLETED ·Phase: PHASE2
-
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
NCT05941520 ·Status: RECRUITING ·Phase: PHASE2